Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension
Authors
Keywords
-
Journal
AIDS
Volume 25, Issue 11, Pages 1347-1356
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-04-19
DOI
10.1097/qad.0b013e328347bd77
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dissecting the human immunologic memory for pathogens
- (2011) Christina E. Zielinski et al. IMMUNOLOGICAL REVIEWS
- Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
- (2010) Laurent Hocqueloux et al. AIDS
- Impact of Viral Dose and Major Histocompatibility Complex Class IB Haplotype on Viral Outcome in Mauritian Cynomolgus Monkeys Vaccinated with Tat upon Challenge with Simian/Human Immunodeficiency Virus SHIV89.6P
- (2010) A. Cafaro et al. JOURNAL OF VIROLOGY
- Innate immunity against HIV: a priority target for HIV prevention research
- (2010) Persephone Borrow et al. Retrovirology
- Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy
- (2010) Mark G Lewis et al. Retrovirology
- Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion
- (2010) Olivier Bourry et al. Retrovirology
- HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
- (2010) D. Trono et al. SCIENCE
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies
- (2009) Laurence Colin et al. Retrovirology
- "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
- (2009) Andrea Savarino et al. Retrovirology
- Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages
- (2008) Shinha Han et al. ARCHIVES OF PHARMACAL RESEARCH
- The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation
- (2008) Andrew G. Cox et al. BIOCHEMICAL PHARMACOLOGY
- Auranofin promotes retinoic acid- or dihydroxyvitamin D3-mediated cell differentiation of promyelocytic leukaemia cells by increasing histone acetylation
- (2008) S J Park et al. BRITISH JOURNAL OF PHARMACOLOGY
- Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells
- (2008) Maria Pia Rigobello et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phenotypic classification of human CD4+ T cell subsets and their differentiation
- (2008) R. Okada et al. INTERNATIONAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now